Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis

Journal of Medical Virology

Volumn 78, Issue 5, 2006, Pages 683-692

  Collenberg, Ellen ^a   Ouedraogo, Thierry ^b   Ganamé, Jean ^c   Fickenscher, Helmut ^a,d   Kynast Wolf, Gisela ^a   Becher, Heiko ^a   Kouyaté, Bocar ^c   Kräusslich, Hans Georg ^a   Sangaré, Lassana ^b   Tebit, Denis M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b CENTRE HOSPITALIER UNIVERSITAIRE YALGADO OUÉDRAOGO   (Burkina Faso)

^c CENTRE DE RECHERCHE EN SANTÉ DE NOUNA   (Burkina Faso)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Dengue virus epidemiology; HBV; HCV; HHV 8; HIV; HTLV

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BURKINA FASO; DENGUE VIRUS; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREGNANCY; RURAL AREA; SEROPREVALENCE; SUPERINFECTION; URBAN AREA; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOOD DONORS; BURKINA FASO; COMORBIDITY; DENGUE; DENGUE VIRUS; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV ANTIBODIES; HIV INFECTIONS; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROEPIDEMIOLOGIC STUDIES;

DENGUE VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 33645917375     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20593     Document Type: Article

References (47)

1. Anonymous. 2001. Conseil National de Lutte contre le SIDA BF. Données de sérosurveillance sentinel, Bull Retro-Inform.
2. Ariyoshi K, Schim van der Loeff M, Cook P, Whitby D, Corrah T, Jaffar S, Cham F, Sabally S, O'Donovan D, Weiss RA, Schulz TF, Whittle H. 1998. Kaposi's sarcoma in the The Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1:193-199.
3. Biggar RJ, Neequaye JE, Neequaye AR, Ankra-Basu GA, Levine PH. 1993. The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa. AIDS Res Hum Retroviruses 9:505-511.
4. Combe P, La Ruche G, Bonard D, Ouassa T, Faye-Ketté H, Sylla-Koko F, Dabis F. 2001. Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Côte d'Ivoire, West Africa. Trans R Soc Trop Med Hyg 95:493-496.
5. Del Mistro A, Chotard J, Hall AJ, Fortuin M, Whittle H, De Rossi A, Chieco-Bianchi L. 1994. HTLV-I/II seroprevalence in The Gambia: A study of mother-child pairs. AIDS Res Hum Retroviruses 10: 617-620.
6. Di Bisceglie AM. 1997. Hepatitis C and hepatocellular carcinoma. Hepatology 26:34S-38S.
7. Diallo MS, Sylla, Sidibé K, Sylla BS, Trepo CR, Wild CP. 1995. Prevalence of exposure to aflatoxin and hepatitis B and C virus in Guinea, West Africa. Natural Toxins 3:6-9.
8. Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, Biberfeld P, Carlberg H, Ljungman P, Nilsson A, Soderstrom T, Wadstrom J, Linde A. 2000. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: Variable frequencies found in a multicenter serological study. J Med Virol 62:498-504.
9. Engels EA, Sinclair MD, Biggar RJ, Whitby D, Ebbesen P, Goedert JJ, Gastwirth JL. 2000. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta. Int J Cancer 88:1003-1008.
10. Fagbami AH. 1978. Human arthropod-borne virus infections in Nigeria. Serological and virological investigations at Shaki, Oyo State. J Hyg Epidemiol Microbiol Immunol 2:184-189.
11. Fagbami AH, Monath TP, Fabiyi A. 1977. Dengue virus infections in Nigeria: A survey for antibodies in monkeys and humans. Trans R Soc Trop Med Hyg 71:61-65.
12. Fiore JR, Volpe A, Tosatti MA, De Valentin L, Favia A, Chironna M, Lisco A, Vimercati A, Angarano G, Chieco-Bianchi L, Calabrò ML. 2004. High seroprevalence of human herpesvirus 8 (HHV-8) in HIV-1-infected pregnant women of southern Italy: Association with injection drug use and hepatitis C virus infection. J Med Virol 72:656-660.
13. Gessain A, Mauclère P, van Beveren M, Plancoulaine S, Ayouba A, Essame-Oyono JL, Martin PM, De Thé G. 1999. Human Herpesvirus 8 Infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 81:189-192.
14. Hladik W, Dollard SC, Downing RG, Kataaha P, Pellett PE, Karon JM, Mermin J, Lackritz EM. 2003. Kaposi's sarcoma in Uganda: Risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 33:206-210.
15. Holmgren B, Da Silva Z, Larsen O, Vastrup P, Andersson S, Aaby P. 2003. Dual infections with HIV-1, HIV-2 and HTLV-I are more common in older women than in men in Guinea-Bissau. AIDS 17:241-253.
16. Houinato D, Verdier M, Josse R, Zohoun T, Letenneur L, Salamon R, Denis F, Preux PM. 1996. Seroepidemiological study of retroviruses (HTLV-I/II, HIV-1, HIV-2) in the Department of Atacora, northern Benin. Trop Med Int Health 1:205-209.
17. Jeannel D, Kourouma K, Fretz C, Zheng YM, Ureta VA, Dramé L, Gessain A, Fournel JJ, De Thé G. 1995. Regional differences in human retroviral infections HIV-1, HIV-2, and HTLV-I/II in rural Guinea (West Africa). J Acquir Immune Defic Syndr Hum Retrovirol 8:315-318.
18. Jeannel D, Fretz C, Traore Y, Kohdjo N, Bigot A, Gamy EP, Jourdan G, Kourouma K, Maertens G, Fumoux F, Fournel JJ, Stuyver L. 1998. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 55:92-97.
19. Klaskala W, Brayfield BP, Kankasa C, Bhat G, West JT, Mitchell CD, Wood C. 2005. Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. J Med Virol 75:93-100.
20. Lagarde E, Congo Z, Meda N, Baya B, Yaro S, Sangli G, Trapre Y, Van Renthergen H, Carael M, Study Group on HIV Dynamic Among Young Adults in Burkina Faso. 2004. Epidemiology of HIV infections in urban Burkina Faso. Int J STD AIDS 15:395-402.
21. Lam SK. 2000. Evaluation of a capture screening enzyme-linked immunosorbent assay for combined determination of immunoglobulin M and G antibodies produced during dengue infection. Clin Diag Lab Immunol 5:850-852.
22. Lang D, Hinderer W, Rothe M, Sonneborn HH, Neipel F, Raab M, Rabenau H, Masquelier B, Fleury H. 1999. Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8. Virology 260: 47-54.
23. Larsen O, Andersson S, Da Silva Z, Hedegaard K, Sandström A, Nauclér A, Dias F, Melbye M, Aaby P. 2000. Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr 25:157-163.
24. Madhava V, Burgess C, Drucker E. 2002. Epidemiology of chonic hepatitis C virus infection in sub-saharan Africa. Lancet Infect Dis 2:293-302.
25. Martin JN, Ganem DG, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. 1998. Sexual transmission and the natural history of human herpesvirus 8 infections. N Engl J Med 338: 948-954.
26. Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ. 2003. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 187:1780-1785.
27. Meda N, Cartoux M, Dabis F, Bazie B, Hetherington J, Dahourou H, Ouangre A, Kpozehouen A, Sombie I, Tiendrebeogo S, Yago S, Ky-Zerbo O, Mandelbrot L, Van de Perre P. 2001. Stabilization of HIV infection rates in Burkina Faso, 1995-1999. Int J STD AIDS 12:460-462.
28. Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, Tamfum JJ, Nébie YK, Maïga I, Ammerlaan W, Fack F, Omilabu SA, Le Faou A, Muller CP. 2004. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 190:400-408.
29. Nacro B, Dao B, Dahourou H. 2001. HBs antigen in children with suspicion of HIV infection. J Trop Pediatr 47:303-304.
30. Newton R, Ziegler J, Bourboulia D, Cassabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaitye S, Jaffe H, Weiss R, Boshoff C, Uganda Kaposi's Sarcoma Study Group. 2003. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. Int J Cancer 103:226-232.
31. Nuvor SV, Katano H, Ampofo WK, Barnor JS, Sata T. 2001. Higher prevalence of antibodies to human herpesvirus 8 in HIV-infected individuals than in the general population in Ghana, west Africa. Eur J Microbiol Infect Dis 20:362-364.
32. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, Whitby D, Nemo GJ, Busch MP, Retrovirus Epidemiology Donor Study. 2003. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 43:1260-1268.
33. Preiser W, Szep NI, Lang D, Doerr HW, Rabenau HF. 2001. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: Evaluation by different test systems. Med Microbiol Immunol 190:121-127.
34. Rezza G, Tchangmena OB, Andreoni M, Bugarini R, Toma L, Bakary DK, Glikoutou M, Sarmati L, Monini P, Pezzotti P, Ensoli B. 2000. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis 27:159-164.
35. Roingeard P, Diouf A, Sankale JL, Boye C, Mboup S, Diadhiou F, Essex M. 1993. Perinatal transmission of hepatitis B virus in Senegal, West Africa. Viral Immunol 6:65-73.
36. Sang TS. 1998. Clinical evaluation of a rapid immunochromatographic test for the diagnosis of dengue virus infection. Clin Diag Lab Immunol 5:407-409.
37. Sangaré L, Sanou I, Kaboré J, Sanon H, Ouédraogo- Traoré R, Drabo YJ, Lengani A, Zombré DS, Soudré RB. 1997. Séroprévalence du virus HTLV-1 dans trios villes et un village du Burkina Faso. Annales de l'Université de Ouagadougou, Series B:103-110.
38. Schatz O, Monini P, Bugarini R, Neipel F, Schulz TF, Andreoni M, Erb P, Eggers M, Haas J, Butto S, Lukwiya M, Bogner JR, Yaguboglu S, Sheldon J, Sarmati L, Goebel FD, Hintermaier R, Enders G, Regamey N, Wernli M, Stürzl M, Rezza G, Ensoli B. 2001. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: Multicentre study with multiple and novel assays. J Med Virol 65:123-132.
39. Simpore J, Granato M, Santarelli R, Aba'a Nsme R, Coluzzi M, Pietra V, Pignatelli S, Bere A, Faggioni A, Angeloni A. 2004a. Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Virol 31:78-80.
40. Simpore J, Ilboudo D, Samandoulougou A, Guardo P, Castronovo P, Musumeci S. 2004b. HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso). J Med Virol 75:209-212.
41. UNAIDS. 2004a. UNAIDS at Country Level. Progress Report. http://www.unaids.org
42. UNAIDS. 2004b. AIDS Epidemic Update. http://www.unaids.org/wad2004/ report.html
43. Verdier M, Densi F, Sangare A, Barin F, Gershy-Damet G, Rey JL, Soro B, Leonard G, Mounier M, Hugon J. 1989. Prevalence of antibody to human T cell leukemia virus type 1 (HTLV-1) in populations of Côte d'Ivoire, West Africa. J Infect Dis 160:363-370.
44. WHO. 2003. Disease Outbreak News. Burkina Faso. 10. October 2003. http://www.who.int/csr/don/2003_10_10/en/
45. WHO. 2004. Disease Outbreak News. Burkina Faso. 24. November 2004. http://www.who.int/csr/don/2004_11_24/en/
46. Williams CK, Dada A, Blattner WA. 1994. Some epidemiological features of the to human T cell leukemia virus type I (HTLV-I) and ATL in Nigerians. Leukemia 8:77-82.
47. Zanchetta N, Vigano P, Ferrario MP, Priuli GB, Djigbenoude O, Nardi GP, Pagano A. 1990. B and delta hepatitis virus infection in a population of West Africa. Rev Inst Med Trop Sao Paulo 30:36-40.